Why is the San Antonio Breast Cancer Symposium so unique and special?ByDebu TripathyDecember 13th 2010
Balancing the benefits and risks of hormonal therapy for early-stage breast cancerByDebu TripathyDecember 10th 2010
DCIS: An example of why screening and disease classification go hand-in-handByDebu TripathyMay 10th 2010
Quality Assurance: How can you make sure you are not a victim of error?ByDebu TripathyFebruary 2nd 2010
San Antonio Breast Cancer Symposium: What have we learned and where are we going?ByDebu TripathyDecember 14th 2009
The importance of cellular pathways and updates on anti-angiogenic drugsByDebu TripathyDecember 11th 2009
